Antiplatelet agents for cancer treatment: a real perspective or just an echo from the past?
about
Motivation for Launching a Cancer Metastasis Inhibition (CMI) Program.Podoplanin - an emerging cancer biomarker and therapeutic target.Novel antibodies against GPIbα inhibit pulmonary metastasis by affecting vWF-GPIbα interactionElevated platelet count is a negative predictive and prognostic marker in locally advanced rectal cancer undergoing neoadjuvant chemoradiation: a retrospective multi-institutional study on 965 patients
P2860
Antiplatelet agents for cancer treatment: a real perspective or just an echo from the past?
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Antiplatelet agents for cancer ...... or just an echo from the past?
@en
type
label
Antiplatelet agents for cancer ...... or just an echo from the past?
@en
prefLabel
Antiplatelet agents for cancer ...... or just an echo from the past?
@en
P2860
P50
P1476
Antiplatelet agents for cancer ...... or just an echo from the past?
@en
P2093
Kenneth V Honn
Stephanie C Tucker
P2860
P2888
P304
P356
10.1007/S10555-017-9683-Z
P577
2017-06-01T00:00:00Z
P6179
1090915850